15. April 2021 – The Federal Government wants to increase the safety of medical devices and their subgroup of in vitro diagnostics and improve patients' safety. To this end, the Therapeutic Products Act is being revised step by step. In March 2019, the Swiss Parliament approved the amendment of the Therapeutic Products Act and the Human Research Act; now the Swiss Medical Devices legislation will be supplemented with the necessary detailed provisions on in vitro diagnostic medical devices. On 14 April 2021, the Federal Council opened the consultation on the new In Vitro Diagnostics Ordinance and the amendments to the Ordinance on Clinical Trials for Medical Devices.

For more information, see here.